These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's disease.
    Author: Csanda E, Tárczy M.
    Journal: Acta Neurol Scand Suppl; 1983; 95():117-22. PubMed ID: 6428143.
    Abstract:
    The experiences of a seven-year study on deprenyl in the treatment of Parkinson's disease are summarized. It was found that the main advantage of deprenyl was that it permitted the reduction of the dose of levodopa in optimally treated patients. In the initial stage of Parkinson's disease deprenyl is only partially sufficient as monotherapy. Deprenyl can administered successfully for correcting the "wearing off" effect.
    [Abstract] [Full Text] [Related] [New Search]